ScholarMate
English简体中文繁體中文
客服热线:400-1616-289
登录注册
期刊论文

Network Pharmacology Analysis and Experimental Verification Strategies Reveal the Action Mechanism of Danshen Decoction in Treating Ischemic Cardiomyopathy

Liu, Mengnan; Yuan, Gang; Luo, Gang; Guo, Xin; Chen, Mingtai; Yang, Huayi; He, Fan; Yang, Tingfu; Zhang, Xinyue; Wu, Qibiao*; Zhou, Hua*; Yang, Sijin*广东省人民医院; 广州中医药大学
Evidence-based Complementary and Alternative Medicine2022-5-2DOI: 10.1155/2022/7578055
6被引21阅读
引用收藏
分享

摘要

Background. Danshen Decoction comprises Salvia miltiorrhiza, Santalum album, and Amomum villosum. It can promote blood circulation and remove blood stasis, and is commonly used in the treatment of gastric and duodenal ulcers, coronary heart disease, angina pectoris, etc. This research is based on network pharmacology and is experimentally verified to explore the potential mechanism of Danshen Decoction in the treatment of ischemic cardiomyopathy (ICM). Methods. The effective components and targets of Danshen Decoction were firstly extracted from Traditional Chinese Medicine Systems Pharmacology (TCMSP) Database and Analysis Platform, the drug-component-target-disease network was then constructed, the protein-protein interaction (PPI) network was constructed, the Gene Ontology (GO) enrichment analysis was carried out, and the Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway was analyzed in order to find the potential active components and therapeutic mechanisms. Finally, the in vitro hypoxia/reoxygenation model in H9c2 cells was established to verify the predicted active components and therapeutic mechanisms. Results. The results showed that Danshen Decoction has 67 potential active components and 109 therapeutic targets in treating ICM. These targets were rich in a variety of gene functions and different signaling pathways; the main gene targets include TP53, c-Jun, and Akt1. Go enrichment analysis showed that response to drug, membrane raft, and G protein-coupled amine receiver activity rank first in each process, and the main signaling pathways include PI3K-Akt signaling pathway. Through molecular docking and experimental verification of the major active components and core therapeutic targets, the active components of Danshen Decoction demonstrated an ability to reduce the cell damage caused by hypoxia/reoxygenation in H9c2 cells by regulating the core therapeutic target including Akt1, c-Jun, and TP53. Conclusion. Danshen Decoction has the effect of treating ICM in multiple ways, which is consistent with the results of network pharmacology. This laid a foundation for further study in exploring the active principles and pharmacological mechanism of Danshen Decoction.

学科与关键词

关键词
HEART-FAILUREAPOPTOSISMEDICINEPROTECTSINJURYAKT
相关
加载中…
  • Material basis and integrative pharmacology of danshen decoction in the treatment of cardiovascular diseases
    Liu, Mengnan; Li, Ziyi; Ouyang, Yue; Chen, Mingtai; Guo, Xin; Mazhar, Maryam; Kang, Junli; Zhou, Hua*; Wu, Qibiao*; Yang, Sijin*PHYTOMEDICINE, 2023, 108: 154503.被引 2
  • Uncovering the Effect and Mechanism of Rhizoma Corydalis on Myocardial Infarction Through an Integrated Network Pharmacology Approach and Experimental Verification
    Li, Jingyan; Wu, Junxuan; Huang, Junying; Cheng, Yuanyuan; Wang, Dawei*; Liu, Zhongqiu*Frontiers in Pharmacology, 2022, 13: 927488.被引 4
  • Network pharmacology provides a systematic approach to understanding the treatment of ischemic heart diseases with traditional Chinese medicine
    Yang, Hua-Yi; Liu, Mengnan; Luo, Pei*; Yao, Xin-Sheng*; Zhou, Hua*PHYTOMEDICINE, 2022, 104: 154268.被引 24
查看全部 →

发表信息

论文状态
公开发表
期刊
Evidence-based Complementary and Alternative Medicine
发表日期
2022-05-02
卷期
第 2022 卷
页码
7578055
DOI
10.1155/2022/7578055
语言
ENGLISH
期刊等级
4区
成果收录
SCIE
资助标注
National Natural Science Foundation of China [82074378]; Science and Technology Development Fund, Macao SAR [0001/2021/AKP, 0098/2021/A2]; Science and Technology Planning Project of Guangdong Province [2020B1212030008]; National Traditional Chinese Medicine Inheritance and Innovation Team [ZYYCXTD-C-202207]; Southwest Medical University Project [2021ZKQN143]

作者

  • L

    Liu, Mengnan (第一作者)

  • Y

    Yuan, Gang

查看全部 12 位作者收起作者
  • L

    Luo, Gang

  • G

    Guo, Xin

  • C

    Chen, Mingtai

  • Y

    Yang, Huayi

  • H

    He, Fan

    guangdong prov acad chinese med sci · guangdong prov hosp · guangzhou univ chinese med

  • Y

    Yang, Tingfu

  • Z

    Zhang, Xinyue

  • W

    Wu, Qibiao (通讯)

  • Z

    Zhou, Hua (通讯)

    guangdong prov acad chinese med sci · guangdong prov hosp · guangzhou univ chinese med

  • Y

    Yang, Sijin (通讯)

登录解锁更多功能

  • 收藏这篇,随时在“我的 · 收藏”找回
  • 认领你的成果,生成推广素材
  • 关注作者获取最新成果
  • 加入项目组、协同写作
注册 / 登录

产品服务

  • 科研之友
  • 创新城
  • 科创云

服务支持

  • 帮助中心
  • 隐私政策
  • 服务条款

联系方式

在线客服:【】
客服热线:400-1616-289
电子邮箱:support@scholarmate.com

关注或下载科研之友

微信二维码
微信公众号
客户端下载二维码
下载客户端
科研成果科研人员科研机构科研动态爱瑞思软件

©2026 深圳市科研之友网络服务有限公司

公安备案图标粤公网安备 44030502000213
粤ICP备 16046710 号粤B2-20110417